Epstein David R
SEC-identified person · CIK 1445826 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Tempus AI, Inc. TEM | Director | filed 2024 - 2026 |
| Agomab Therapeutics NV AGMB | Director | filed 2026 - 2026 |
| Seagen Inc. SGEN | Director · Chief Executive Officer | filed 2022 - 2023 |
| Senti Biosciences, Inc.\ SNTI | Director | filed 2021 - 2022 |
| Evelo Biosciences, Inc. EVLO | Director | filed 2018 - 2022 |
| Axcella Health Inc. AXLA | Director | filed 2019 - 2022 |
| Rubius Therapeutics, Inc. RUBY | Director | filed 2018 - 2022 |
| Opy Acquisition Corp. I OHAA | Director | filed 2021 - 2021 |
| International Flavors & Fragrances INC IFF | Director | filed 2016 - 2020 |
| Molecular Insight Pharmaceuticals, Inc. mipi | Director | filed 2008 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.